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Ethylene (ET) is metabolized in mammals to the carcinogenic
ethylene oxide (EO). Although both gases are of high industrial
relevance, only limited data exist on the toxicokinetics of ET in
mice and of EO in humans. Metabolism of ET is related to
cytochrome P450-dependent mono-oxygenase (CYP) and of EO
to epoxide hydrolase (EH) and glutathione S-transferase (GST).
Kinetics of ET metabolism to EO and of elimination of EO were
investigated in headspace vessels containing incubations of
subcellular fractions of mouse, rat, or human liver or of mouse
or rat lung. CYP-associated metabolism of ET and GST-related
metabolism of EO were found in microsomes and cytosol,
respectively, of each species. EH-related metabolism of EO was
not detectable in hepatic microsomes of rats and mice but obeyed
saturation kinetics in hepatic microsomes of humans. In ET-
exposed liver microsomes, metabolism of ET to EO followed
Michaelis-Menten-like kinetics. Mean values of Vmax [nmol/
(min mg protein)] and of the apparent Michaelis constant (Km
[mmol/l ET in microsomal suspension]) were 0.567 and 0.0093
(mouse), 0.401 and 0.031 (rat), and 0.219 and 0.013 (human). In
lung microsomes, Vmax values were 0.073 (mouse) and 0.055 (rat).
During ETexposure, the rate of EO production decreased rapidly.
By modeling a suicide inhibition mechanism, rate constants for
CYP-mediated catalysis and CYP inactivation were estimated. In
liver cytosol, mean GST activities to EO expressed as Vmax/Km
[ml/(min mg protein)] were 27.90 (mouse), 5.30 (rat), and 1.14
(human). The parameters are most relevant for reducing
uncertainties in the risk assessment of ET and EO.
Key Words: ethylene; ethylene oxide; subcellular fractions;
suicide inhibition; mouse; rat; human.
The gaseous oleﬁn ethylene (ET, CAS No.: 74-85-1) is the
largest volume organic chemical produced worldwide. The
estimated global production in 2005 was over 112.9 million
tons. The gas is mainly used as feedstock in the production of
polymers and industrial chemicals (Zimmermann and Walzl,
2007). It is ubiquitously present in the environment, arising
predominantly as a natural product from vegetation, from
burning of organic material, and from automotive engine
exhausts (referenced, for example, in International Agency of
Research on Cancer (IARC), 1994a). Plants produce ET as
a ripening hormone as reviewed in Bleecker and Kende (2000).
Mice (Lawrence and Cohen, 1985), rats (Csana ´dyet al., 2000),
and humans (Filser et al., 1992) exhale endogenously formed
ET. In liver microsomes of rats pretreated with phenobarbital, it
was ﬁrst proved by Schmiedel et al. (1983) that cytochrome
P450-dependent monooxygenases (CYP) epoxidize ET to
ethylene oxide (EO, CAS No.: 75-21-8). EO is a directly
protein- and DNA-alkylating agent in rodents and humans (for
instance, see Boogaard et al., 1999; Huang et al., 2011; Walker
et al., 2000; Wu et al., 2011). It is mutagenic in vitro and
in vivo (reviewed, for example, in Dellarco et al., 1990;
Kolman et al., 2002) and is carcinogenic in rat (Dunkelberg,
1982; Garman et al., 1985; Snellings et al., 1984) and mouse
(Dunkelberg, 1981; National Toxicology Program, 1987). In
EO-exposed humans, increased sister chromatid exchange and
chromosomal aberrations were reported (reviewed in Kolman
et al., 2002). Based on the results of several epidemiologic
studies on EO-exposed workers and mechanistic evidences,
IARC (1994b) evaluated EO as carcinogenic to humans.
In vivo, the formation of EO from ET was shown indirectly
in rats, mice, and humans via characteristic adducts to
macromolecules (Ehrenberg et al., 1977; Eide et al., 1995;
Filser et al., 1992; Rusyn et al., 2005; Segerba ¨ck, 1983;
To ¨rnqvist et al., 1989; Walker et al., 2000) and directly in ET-
exposed rats determined as EO in exhaled air (Filser and Bolt,
1984) and as EO in blood (Fennell et al., 2004; Maples and
Dahl, 1993). In spite of the formation of its carcinogenic
metabolite EO, ET was found to be negative in mutagenicity
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1988; Walker et al., 2000) and in a long-term carcinogenicity
study in rats (Hamm et al., 1984). The negative outcome of the
carcinogenicity study was expected from toxicokinetic studies
with ET and EO in rats and from studies on hemoglobin
adducts in rats and mice. The EO burden was predicted to be
too low to lead to tumors in a long-term carcinogenicity study
with ET (Bolt and Filser, 1984; Osterman-Golkar and
Ehrenberg, 1982; Walker et al., 2000).
Toxicokinetic data on EO were obtained in blood of mice
during, and in blood, brain, muscles, and testes of mice and rats
after exposing the animals up to 4 h to constant concentrations of
atmospheric EO (Brown et al.,1 9 9 6 , 1998). Also, concentration-
time courses of EO were monitored in the atmosphere of closed
exposure chambers after the exposure of mice for 3 h to constant
EO concentrations (Sega et al.,1 9 9 1 ). In this species, no
measured toxicokinetic data on ET are published neither in vivo
nor in vitro. In humans, the kinetics of ET was investigated only
at low ET concentrations (< 50 ppm) by means of gas uptake
studies (Filser et al.,1 9 9 2 ). Brugnone et al. (1985, 1986)
reported EO concentrations in blood and ratios of alveolar to
atmospheric EO concentrations in EO-exposed workers. Gas
uptake experiments were also conducted to investigate in rats the
kinetics of ET (Andersen et al.,1 9 8 0 ; Bolt et al.,1 9 8 4 )a n do f
EO (Filser and Bolt, 1984; Krishnan et al.,1 9 9 2 ). EO was
rapidly eliminated following ﬁrst-order kinetics at EO concen-
trations of up to at least 100 ppm. ET showed saturation kinetics
that could be described according to Michaelis and Menten by
Vmax and an apparent Michaelis constant (Km). The metabolic
elimination of ET was quantitatively inhibited following
pretreatment with sodium diethyldithiocarbamate; Vmax was
doubled after pretreatment with a mixture of polychlorinated
biphenyls (Bolt et al.,1 9 8 4 ). These results hinted to a CYP-
mediated metabolism of ET, later conﬁrmed by Fennell et al.
(2004). In rats exposed to high ET concentrations (Filser and
Bolt, 1984: > 1000 ppm; Fennell et al.,2 0 0 4and Maples and
Dahl, 1993: 600 ppm), metabolically formed EO increased
rapidly in exhaled air and in blood shortly after starting the
exposures. Thereafter, the EO concentrations declined, reaching
plateaus (Filser and Bolt, 1984; Maples and Dahl, 1993) that
remained rather constant until the end of exposure. The decline
of EO was explained by an inactivation of hepatic CYP down to
68% after 360 min of exposure (Maples and Dahl, 1993)a n do f
hepatic 4-nitrophenol hydroxylase activity (predominantly
CYP2E1) to 50% after 4 h (Fennell et al.,2 0 0 4 ). The loss of
CYP activity reﬂects the ﬁndings in liver microsomes of
phenobarbital-pretreated rats that ET destroyed CYP by self-
catalyzed prosthetic heme alkylation (Ortiz de Montellano and
Correia, 1983; Ortiz de Montellano and Mico, 1980).
ToxicokineticdataofETand EO inmice,rats,and humanswere
used for developing physiological toxicokinetic models of ET
togetherwithEO(Csana ´dyetal.,2000)orsolelyofEO(Fennelland
Brown, 2001; Krishnan et al., 1992). However, a toxicokinetic
model that describes the initial EO blood peaks together with the
concentration-time courses of the ET-metabolizing CYP species
during exposure to ET is missing. Such a model is required for
providingaquantitativebasisfortheassessmentoftheriskofETto
humans. The goal of the present work was to acquire the
toxicokinetic parameters that are necessary for the model by using
ET- and EO-exposed subcellular fractions of livers and lungs of
mice and rats and of livers of humans.
MATERIALS AND METHODS
Chemicals
ET 3.5 (> 99.95%) and EO 3.0 (> 99.9%) were obtained from Linde,
Unterschleissheim, Germany. Reduced glutathione (GSH;   99%), pig heart
isocitrate dehydrogenase Type IV, buffered to pH 6.0 in 50% aqueous glycerol
solution (13 or 15 U/mg protein), D,L-isocitric acid trisodium salt (96%),
b-nicotinamide adenine dinucleotide phosphate sodium salt (NADP
þ; 97%),
and b-nicotinamide adenine dinucleotide 2#-phosphate reduced tetrasodium salt
(NADPH; 97%) were purchased from Sigma-Aldrich, Steinheim, Germany.
Racemic propylene oxide (PO; 99.9%) was provided by Serva GmbH,
Heidelberg, Germany. All other chemicals were from Linde; Merck, Darmstadt,
Germany; and Sigma-Aldrich at the highest analytical grade available.
Animals
Male B6C3F1 mice and male Fischer 344 rats were obtained from Charles
River, Sulzfeld, Germany. Male 129/Sv-Cyp2e1tm1Gonz/J mice (CYP2E1
knockout mice) were bred in-house from three pairs of revitalized mice of this
strain that were obtained from The Jackson Laboratory, Bar Harbor, ME. Male
129S1/SvImJ mice (wild-type mice) were also obtained from The Jackson
Laboratory. CYP2E1 knockout and the corresponding wild-type mice were
used only to investigate the relevance of CYP2E1 on the ET metabolism. All
animals were housed in macrolon type III cages in an IVC top-ﬂow system
(Tecniplast, Buguggiate, Italy). A light and dark cycle of 12 h was maintained
in the animal room. The animals were kept at constant room temperature (23 C)
and received standard diet 1324 (Altromin, Lage, Germany) and tap water ad
libitum. Immediately before harvesting the livers and lungs for the preparation
of microsomes and cytosol, the animals (mice about 25 g and rats about 250 g
body weight) were asphyxiated with carbon dioxide.
Human Liver Samples and Subcellular Human Liver Fractions
A sample of a liver of a 75-year-old woman was obtained from the
University Hospital ‘‘Rechts der Isar’’ of the ‘‘Technische Universita ¨t
Mu ¨nchen’’, Munich, Germany. The donor, suffering from metastasis of rectum
cancer, was not treated with oncological drugs when the liver sample was
collected on the occasion of a liver transplantation. The other liver samples
were from ﬁve male and one female trauma victims who were between 16 and
58 years of age. All these liver samples were obtained at autopsies carried out in
the forensic ‘‘Institut fu ¨r Rechtsmedizin’’ of the ‘‘Ludwig-Maximilians-
Universita ¨t Mu ¨nchen’’, Munich, Germany. Death occurred between 6.5 and
29 h prior to autopsy. The liver samples were used to prepare cytosol in order to
test the glutathione S-transferase (GST) activity to EO as substrate. In addition,
microsomes were prepared from the liver samples of the 75-year-old woman
and of a 22-year-old man who died 6.5 h before autopsy. Immediately after
collection, the samples were stored at  20 C until transport (on ice) within 30
min to the Institute of Toxicology of the Helmholtz Center Munich, where they
were stored at  80 C until preparation of the subcellular liver fractions.
Liver cytosol of 6 human individuals (1 male, 5 female; 42–78 years old) and
microsomes pooled from the livers of 18 male and 7 female Caucasian and
Hispanic donors, 21–64 years old, as well as cytosol pooled from the livers of
ETHYLENE AND ETHYLENE OXIDE KINETICS IN RODENT AND HUMAN TISSUES 3851 female Afro-American, 1 male Asian, 5 female and 3 male Caucasians, and
1 male Hispanic subject, between 1.9 and 70 years old, were obtained from BD
Biosciences, San Jose ´, CA and delivered from Becton Dickinson, Heidelberg,
Germany. Microsomes consisted of 20 mg protein/ml in a sucrose solution
(250 mmol/l). Cytosol (protein content 20 mg/ml) was in a solution consisting of
150 mmol/l KCl, 50 mmol/l Tris-HCl buffer (pH 7.5), and 2 mmol/l EDTA.
Preparation of Microsomes and Cytosol
Microsomes and cytosol were prepared from tissue samples as described in
Kreuzer et al. (1991). Both fractions were stored at  80 C until use. The
protein content of the subcellular fractions was determined using a modiﬁed
Biuret method (Gornall et al., 1949).
Incubation Procedure
All the experiments described in the following are ‘‘gas uptake experiments’’
with the gaseous compound administered only once into the atmosphere of closed
all-glass exposure vessels. Microsomal and cytosolic incubation conditions were
chosen as described in Kreuzer et al. (1991) and in Faller et al. (2001).I nt h e
latter publication, the quality of such preparations was veriﬁed by comparing
speciﬁc activities of CYP, GST, and epoxide hydrolase (EH) for a series of
standard substrates with literature data. The protein concentrations used in the
present work were selected according to Faller et al. (2001).G e n e r a l l y ,
a subcellular fraction, either native or inactivated by heat (96 C for 10 min in
a water bath), was incubated with ET or EO with or without coenzymes in
a cone-shaped headspace vessel (~38 ml). The all-glass vessel contained two
ports, one at the upper end, closed by a stopcock made out of glass, and one
laterally, closed by a Teﬂon-coated rubber septum. It was located at 37 Ci n
a continuously vigorously shaken water bath. Concentration-time courses of ET
and EO were monitored by gas chromatography with ﬂame ionization detection
(GC/FID) using gas samples collected periodically from the headspace,
immediately after shortly but vigorously shaking the vessel by hand in order to
maintain the compound-speciﬁc partition coefﬁcient incubation medium-to-air.
Microsomal Incubations
Ethylene. The headspace vessels contained microsomes, MgCl2 (5 mmol/l
in the ﬁnal incubate volume) and potassium phosphate buffer (0.15 mol/l, pH
7.4). In those experiments in which only ET was monitored, either hepatic
microsomal suspensions of 10 ml with protein concentrations of 10 mg/ml in the
38-ml vessels or hepatic microsomal suspensions of 4 ml with protein
concentrations of 5 mg/ml in commercially available 8-ml headspace vials were
used. When monitoring additionally the EO formation in ET incubations,
volumes and protein concentrations of the hepatic microsomal suspensions in the
38-ml vessel were 4 ml and 2.5 mg/l (B6C3F1 and wild-type mice), 4 ml and
5 mg/ml (rats), and 2 ml and 10 mg/ml (humans and CYP2E1 knockout mice). In
incubations of mouse and rat lung microsomes, suspensions consisted of 2 ml
with protein concentrations of 5 mg/ml (mice) and 10 mg/ml (rats). For the
administration of ET, the gas phase of the vessel was totally exchanged by
pumping 100 ml of a gas sample containing the speciﬁed ET concentration
through the vessel using a 100-ml syringe equipped with a cannula and a second
cannula both of which piercing the septum. An NADPH-regenerating system
(NADP 1 mmol/l, isocitrate 8 mmol/l, and isocitrate dehydrogenase 0.2 U/l
phosphate buffer) was prepared in a 2-ml-Eppendorf cup. In order to study CYP-
dependent metabolic ET elimination or EO formation, both the headspace vial
and the Eppendorf cup with the NADPH-regenerating system were preincubated
in the water bath for 5 min. Then, the incubation was started by injecting 0.64 ml
(for the 2-ml suspension) or 1.28 ml (for the 4-ml suspension) of the NADPH-
regenerating system through the septum into the headspace vessel. Control
experiments were conducted with heat-inactivated microsomes.
Ethylene oxide. The 38-ml vessels contained microsomes (5 mg protein/
ml), MgCl2, and phosphate buffer as described above. The volume of each
suspension was 1 ml. After preincubating the vessel in the water bath for 10
min, a deﬁned volume of air was removed by a gastight glass syringe. In order
to investigate the microsomal EH-catalyzed EO elimination, the incubation was
started by injecting an EO air mixture equal to the amount of air that had been
removed before. The EO volume required to achieve initial concentrations in
the gas phase of between 10 and 10,000 ppm in the vessel had been calculated
taking into account the EO concentration in the storage desiccator and the
thermodynamic partition coefﬁcient medium-to-air of EO (KeqEO, see below).
In order to test whether EO was metabolized by CYP450, an incubation of EO
was carried out in pooled rat liver microsomes in the presence of the above-
described NADPH-regenerating system. Control experiments were done with
heat-inactivated microsomes.
Cytosolic Incubations
Cytosolic incubations were done only with EO. The 38-ml vessels contained
cytosol (3 mg protein/ml), MgCl2 (5 mmol/l), mostly GSH (15 mmol/l), and
phosphate buffer (0.15 mol/l, pH 7.4). The total volume of the liquid phase was
always 1 ml. After a preincubation period of 10 min, a deﬁned volume of air
was removed from the vessel and replaced by an EO air mixture hereby starting
the exposure. In order to investigate the GST-mediated EO elimination, initial
EO concentrations of between 10 and 3000 ppm were used. Control
experiments were done with heat-inactivated cytosol in the absence of GSH
but in the presence of maleic acid diethyl ester (DEM, 3 mmol/l incubation
medium) for the depletion of residual GSH (Boyland and Chasseaud, 1970).
For determining the nonenzymatic conjugation of EO with GSH, incubations
were done with heat-inactivated cytosol and GSH (15 mmol/l in the incubation
medium). For investigating whether the presence of cytosolic proteins might
have an inﬂuence on the rate of EO hydrolysis, some EO incubations were
carried out in the presence of native cytosol and DEM (3 mmol/l incubation
medium).
Gas Chromatographic Analysis
Atmospheric ET, EO, and PO (a proven EH substrate that was used for
comparative purposes, see below) were analyzed according to Faller et al. (2001)
using gas chromatographs GC-8A (Shimadzu, Duisburg, Germany) equipped
with ﬂame ionization detectors and the integrators CR5A and CR6A (from
Shimadzu) for recording the chromatograms. Separation was carried out on 1/8$
stainless-steel columns ﬁlled with Tenax TA from Chrompack, Frankfurt,
Germany (60–80 mesh for ET and 80–100 mesh for EO and PO). The column
used for ET was 1.5 m that for EO and PO 3.5 m long. Nitrogen with pressures of
200 (ET, PO) or 250 (EO) kPa was used as carrier gas. The oven temperatures
were 60 C( E T ) ,1 5 0  C (EO), and 180 C (PO). The temperatures of the injectors
and detectors were held at 130 C (ET), 200 C (EO), or 230 C (PO). The
detectors were provided with hydrogen (60 kPa) and synthetic air (60 kPa). Gas
samples of 50 ll (ET, PO, and EO  10 ppm in the vessel atmosphere) and of 500
ll( E O< 10 ppm) were injected directly onto the column. The retention times of
the gases were 0.5 min (ET), 2.5 min (EO), and 2.4 min (PO).
Calibration curves were constructed with the three substances in the ranges
of between 200 and 50,000 ppm (ET), 5 and 5000 ppm (EO; injection volume
50 ll), 0.22 and 10.02 ppm (EO; injection volume 500 ll), and 10 and 1000
ppm (PO). Linear regression analysis through the origin revealed correlation
coefﬁcients of at least 0.999 between peak height and gas concentration. The
detection limits, deﬁned as three times the background noise, were 0.1 ppm
(ET), 0.5 ppm (EO; injection volume 50 ll), 0.1 ppm (EO; injection volume
500 ll), and 0.3 ppm (PO).
For each exposure, a single calibration of each measured compound was
performed.
Kinetic Analysis of Concentration-Time Courses
Atmospheric concentrations given in ppm at 37 C were transformed to mol/l
by division with the molecular volume of an ideal gas at 37 C (25.43 l). Actual
amounts N(t) of compounds in the vessel were obtained by multiplication of the
actual concentration in air ca(t) with the compound-speciﬁc volume of
distribution Vd:
386 LI ET AL.NðtÞ ¼ caðtÞ   Vd ð1Þ
Because the vessels were always vigorously shaken, Vd is always the sum of the
air volume Vg in the vessel and the product of the volume of the liquid phase Vl
in the vessel with the compound- and medium-(cytosolic or microsomal
incubation) speciﬁc thermodynamic partition coefﬁcient medium-to-air Keq:
Vd ¼ Vg þ Vl   Keq ð2Þ
The values of Keq (KeqET for ET and KeqEO for EO) were determined at 37 C
according to Csana ´dy et al. (2000). They were KeqET ¼ 0.2 ± 0.06 (n ¼ 5) and
KeqEO ¼ 68.4 ± 0.6 (n ¼ 3) in microsomal incubations. In cytosolic
suspensions, KeqEO was 75.9 ± 3.1 (n ¼ 3).
In the ET or EO gas uptake studies, the atmospheric concentration-time
courses of ET or EO were ﬁtted using an e-function (Equation 3) or a differential
equation describing saturation kinetics according to Michaelis and Menten
(Equation 4).
ca ¼ cað0Þ   e k t þ A ð3Þ
The concentration in the air phase of the vessel is represented by ca and the
elimination rate constant by k. ‘‘A’’ means a constant concentration of A   0.
dCa=dt ¼ 
 
V 
max   Ca
 
=
 
K 
m þ Ca
 
ð4Þ
V
*
max is the maximum concentration change in the atmosphere of the vessel.
K
*
m is the apparent Michaelis constant related to the atmospheric concentration.
With the amount of protein (Pr) in the experimental onset, the expression
V 
max   Vd=Pr gives the maximum elimination rate Vmax (amount of compound
per time unit per mg protein):
Vmax ¼ V 
max   Vd=Pr ð5Þ
The compound- and species-speciﬁc value of Km (the apparent Michaelis
constant related to the incubation medium) is given by the product of K
*
m with
Keq (for deﬁnition of Keq, see above):
Km ¼ K 
m   Keq ð6Þ
In ET incubation experiments with quasi-constantly remaining ET
concentrations, metabolically formed EO was detected in the air phase of the
exposure systems. Because the EO formation took place only in the liquid
phase, each measured air-phase concentration cEOa was used to calculate the
corresponding amount of EO in the whole system and relating it to the volume
of the liquid phase, solely:
cEOl ¼
cEOa  
 
Vg þ KeqEO   VI
 
V1
ð7Þ
Here, cEOl is the ‘‘theoretical’’ EO concentration in the liquid phase and KeqEO
is the thermodynamic partition coefﬁcient of EO in microsomal incubations.
The following function was ﬁtted to the time-dependent, experimentally
obtained cEOl data. This function was derived from theoretical considerations (see
below):
cEOl ¼ C1  
 
1 e k t 
ð8Þ
C1 is the ﬁtted EO concentration for t/N and k is a rate constant.
Initial formation rates of EO (vinit), normalized to a protein content of 1 mg,
were calculated from the derivative of Equation 8 at t ¼ 0 by taking into
account Vl and the actual amount of protein (Pr):
vinit ¼
k   C1   Vl
Pr
ð9Þ
By means of the program Prism 5 for Macintosh (GraphPad Software,
California) Michaelis-Menten-type kinetics were ﬁtted to the data representing
various vinit values of EO against the corresponding ET substrate concen-
trations. The Berkeley Madonna 8.3.18 (University of California, Berkeley)
program was used to ﬁt Michaelis-Menten-type kinetics to the human
microsomal EO concentration-time data.
Suicide Inhibition Model
The CYP-mediated metabolic production of EO from ET together with the
irreversible inactivation of CYP (by N-hydroxyethylation of the pyrrole ring D
in the porphyrin; reference, for e.g., Correia and Ortiz de Montellano, 2005)
was described by the following reaction scheme (adapted from Collman et al.,
1990), which incorporates the metabolite formation via the enzyme-substrate
complex ES according to Briggs and Haldane (1925) together with
simultaneous suicide inactivation of ES.
ð10Þ
The concentration of the ET-metabolizing CYP species is given by E,t h a to f
the substrate ET by S, and that of the product EO by P. EX stands for irreversibly
inactivated CYP. The rate constants of the four reactions shown in Equation 10
are represented by k1,k 2,k 3, and k4.I nt h el i t e r a t u r e ,k 3 is often named ‘‘kcat’’ and
k4, the inactivation constant, ‘‘kinact.’’ The co-substrates O2 and NADPH are not
considered because O2 was in excess and NADPH was assumed constant during
the exposure period because of the NADPH regeneration system. According to
Equation 10, the change of ES over time (t) is described by:
dES
dt
¼ k1   S   E  
 
k2 þ k3
 
  ES   k4   ES ð11Þ
When the rate of the suicide inhibition
dEX
dt
¼ k4   ES ð12Þ
is zero, Equation 11 reads
dES
dt
¼ k1   S   E  
 
k2 þ k3
 
  ES ð13Þ
As discussed by Briggs and Haldane (1925), dES
dt in Equation 13 can be
considered negligibly small. In other words, the expression given at the right
side of Equation 13 can be treated as zero. Taking this assumption of a very fast
quasi-steady state into account and considering dEX
dt (see Equation 12) being
much slower than the time to reach the quasi-steady-state, Equation 11 can be
reformulated to:
dES
dt
¼  k4   ES ð14Þ
At the experimental onset used in the present microsomal studies, the ES
complex was already formed in the preincubation phase before the reaction was
started by the addition of the NADPH regenerating system. During this phase, both
k3 and k4 are evidently not existent (compare Equation 10); the ES complex ES0 at
t ¼ 0 (the end of the preincubation phase, when the reaction starts) is given by:
k1   E   S ¼ k2   ES0 ð15aÞ
or
ES0 ¼
k1   E   S
k2
ð15bÞ
At the end of the preincubation phase, the total enzyme concentration Et is
given by:
Et ¼ ES0 þ E ð16Þ
Combining Equation 15b with Equation 16 and canceling E, one obtains
ES0 as a function of Et, S, and the rate constants k1 and k2:
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Et   k1   S
k2 þ k1   S
ð17Þ
It can be derived from Equation 17 that ES0 becomes ES0   Et at very high
concentrations of S because k2 can be neglected if compared with k1   S for
such exposure conditions.
The solution of the differential Equation 14 is:
ES ¼ ES0   e k4 t ð18Þ
The exposure time is given by t.
Equation 10 shows that the rate of the ET-derived formation of the EO
concentration
 
dP
dt
 
is represented by:
dP
dt
¼ k3   ES ð19Þ
or with Equation 18:
dP
dt
¼ k3   ES0   e k4 t ð20Þ
Because ES0 becomes equal to Et at very high concentrations of S, the
maximum rate of metabolite formation dPmax
dt (at the time point t(0) ¼ 0, when the
reaction is started) is given by:
dPmax
dt
¼ k3   Et ð21Þ
The concentration-time course of P at a given constant concentration of S is
obtained by integrating Equation 20 and considering that P ¼ 0a tt(0):
P ¼
k3
k4
  ES0  
 
1 e k4 t
 
ð22Þ
The term (k3/k4) is a partition ratio and represents the number of products
formed per one inactivation event. The partition ratio is constant, independent
of the substance concentration. Both reactions (k3   ES) and (k4ES) follow
saturation kinetics.
Linkage of the Suicide Inhibition Model with Experimental Parameters
The amount of ET was much greater in the relatively large atmospheric
volumes of the closed vessels than in the small volumes of the liquid phase,
where the reaction took place because of the very low KeqET of 0.2 (see above).
Consequently and because of the relatively slow metabolic ET elimination, the
substrate concentration ET remained almost constant during the exposure
periods. The maximum EO production VmaxEO was obtained experimentally as
described in the text to Equation 9. Considering ET to be metabolized
exclusively by CYP2E1 (see Results), the mean microsomal CYP2E1 contents
(nmol/mg microsomal protein) of 96 3 10
 3 (SD ¼ 12 3 10
 3; n ¼ 3), 35.8 3
10
 3 (SD ¼ 8.3 3 10
 3; n ¼ 3), and 70.5 3 10
 3 (SD ¼ 17 3 10
 3; n ¼ 30;
weighted mean and SD of three times 10 determinations) in livers of mice, rats,
and humans, respectively (Seaton et al., 1995), were taken as the species
speciﬁc total enzyme concentrations Et. Replacing dPmax
dt in Equation 21 by
VmaxEO/Vl and Et by the CYP2E1 content/Vl, Equation 23 was used to calculate
the value of k3:
k3 ¼
VmaxEO
CYP2E1
ð23Þ
Equation 22 has the same structure as Equation 8. Therefore, the value of the
inactivation constant k4 equals the experimentally obtained value of k in
Equation 8. The concentration k3
k4   ES0 (Equation 22) stays for the experimental
EO plateau concentration C1 which, when multiplied with k4, equals the initial
EO production rate at the corresponding ET exposure concentration and
microsomal protein content (see Equations 9 and 20).
It has to be stressed that the Km values and the rate constants ki dealt with in
the present work are apparent constants because the experiments were not
performed with puriﬁed enzymes. The use of microsomal and cytosolic
suspensions is, however, preferable to that of puriﬁed enzymes because the
translation of in vitro results to the in vivo situation requires fewer assumptions
when using microsomal and cytosolic data.
Statistics
Arithmetic means ( x) and SEs and two-way ANOVA were calculated using
the software Prism 5. SE values were also obtained from SD calculated by
means of Microsoft Excel 2004 for Mac (Microsoft, Unterschleissheim,
Germany) using the following relation:
SE ¼
SD
ﬃﬃﬃ
n
p ð24Þ
with n being the sample size.
Error propagation of SE was calculated as described in Sachs (1973).
RESULTS
Gas Uptake Studies with ET in Microsomal Incubations
Elimination of ET. A series of ET gas uptake studies was
performed using pooled rat liver microsomal incubations in
order to monitor the disappearance of ET in the atmosphere of
the vessels as a measure of ET metabolism. No enzyme-
catalyzed concentration losses could be detected when using
protein concentrations of 5 mg/ml incubate in 8-ml vials as the
very ﬂat slopes of the ET concentration-time courses of
incubations containing native or heat-inactivated microsomes
were almost identical (Fig. 1A). Only when using 38-ml
vessels containing a microsomal suspension of 10 ml with
a high protein concentration of 10 mg/ml, declines of
atmospheric ET could be monitored (Figs. 1B and 1C). The
slopes of the curves ﬁtted to the data in native microsomes
ﬂatten with the exposure time and become, after about 20 min,
parallel to the curves ﬁtted to the data in heat-inactivated
microsomes. The small decay of the latter curves results from
the ET loss due to the sampling of the gas probes. The curves
gained with native microsomes level off with time because of
the suicide inactivation of the ET-metabolizing CYP species
which results from the NADPH-dependent activation of ET
(Ortiz de Montellano and Mico, 1980). The functional integrity
of the hepatic microsomes of the three species was veriﬁed
over a time span of 60 min using gaseous styrene as model
substance (data not shown). Styrene is known to have a very
high partition ratio k3/k4 of 10,000 (determined using
a synthetic iron porphyrin; Collman et al., 1986). Initial rates
of ET elimination were calculated from the e-functions
describing the curves in Figures 1B and 1C.
In mouse liver microsomes, the initial rate of metabolic ET
elimination was 0.069 nmol/min/mg protein at an ET exposure
concentration of 170 ppm in the vessel atmosphere. In rat liver
microsomes, initial rates of 0.022 and 0.051 nmol/min/mg
protein were obtained in two incubations with ET, each of
388 LI ET AL.which with an initial concentration of 200 ppm. At an ET
concentration of 30 ppm, the initial elimination rate was 0.005
nmol/min/mg protein. Figures 1D–F show the concentration-
time courses of ET in those mouse, rat, and human liver
microsomal incubation experiments that were carried out in
order to study the formation kinetics of metabolically produced
EO. The slopes of the ET concentration-time courses result
predominantly from the repeated collection of air samples of 50
and 500 ll each required for determining ET and EO,
respectively, as is evidenced by the concentration-time curves
that represent e-functions calculated by considering the
experimental removal of atmospheric ET, solely. The extent
of metabolic elimination of ET from the vessel atmospheres
was too slight to become discernible.
Formation of EO. The results shown in Figure 2 were
obtained when measuring the EO formation instead of the ET
elimination in a series of ET incubation studies using pooled
liver microsomes of mice (Fig. 2A), rats (Fig. 2B), or humans
(Fig. 2C) and liver microsomes of individual human subjects
(Figs. 2D and 2E)a sw e l la sp o o l e dl u n gm i c r o s o m e so fm i c eo r
rats (Figs. 2F and 2G). In addition, the time courses of EO
formation in ET-exposed pooled hepatic microsomal suspen-
sions of 50 wild-type and 50 CYP2E1 knockout mice are shown
in Figure 2H. The curves describing total EO in the liquid phase
(cEOl, see Equation 7) ﬂatten with the exposure time and
approach plateaus. This ﬁnding corresponds to the ﬂattening of
the ET elimination curve in dependence of the exposure time
(Figs. 1B and 1C).
The curves plotted to the concentration-time data in Figure 2
were ﬁtted by the function given in Equation 8. The rate
constant in Equation 8 equals the apparent suicide inactivation
rate constant k4 of the ET-metabolizing CYP species, which is
predominantly CYP2E1 in the liver. This can be concluded
from the ﬁndings that the maximum rate of EO formation
(VmaxEO) was about 15 times higher in liver microsomes of
wild-type mice (1.1 nmol/min/mg protein) than in the
corresponding CYP2E1 knockout mice (0.074 nmol/min/mg
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FIG. 1. Concentration-time courses of ET at various initial concentrations of ET in the atmosphere of closed exposure vessels containing microsomes from pooled
livers of (A) 10 rats (5 mg protein/ml, incubation volume 4 ml, and vessel volume 8 ml), (B) 50 mice (10 mg protein/ml, incubation volume 10 ml, and vessel volume
38 ml), (C) 10 rats (10 mg protein/ml, incubation volume 10 ml, and vessel volume 38 ml), (D) 50 mice (2.5 mg protein/ml, incubation volume 4 ml, and vessel volume
38 ml), (E) 10 rats (5 mg protein/ml, incubation volume 4 ml, and vessel volume 38 ml), and (F) 25 humans (10 mg protein/ml, incubation volume 2 ml, and vessel
volume 38 ml). Filled symbols, measured atmospheric ET concentrations using ( ) heat-inactivated or ( ) native microsomes; open symbols, time points at which gas
samples were collected for determining metabolically formed EO. The colors of the open symbols and of the dashed lines symbolize the ET uptake experiments of
which the EO productions are shown in Figures 2A–C. Straight lines (A–C), ﬁts of Equation 3 to the data (red, heat-inactivated microsomes and black, native
microsomes); dashed lines (D–F), predicted by taking into account the loss of ET from the vessel by the sampling procedure.
ETHYLENE AND ETHYLENE OXIDE KINETICS IN RODENT AND HUMAN TISSUES 389protein). Even higher (340) was the ratio of VmaxEO/Km in wild-
type mice (162 ll/min/mg protein) to VmaxEO/Km in CYP2E1
knockout mice (0.476 ll/min/mg protein).
Based on the ﬁts to the EO concentration-time data, the
initial EO formation rates vinit were calculated and are
presented for B6C3F1 mice and Fischer 344 rats versus the
ET exposure concentrations in Figure 3. The data obtained in
lung microsomes at high ET concentrations of 16,500 and
75,400 (mice) and of 18,600 and 57,800 ppm (rats) probably
represent the maximum EO formation rates of VmaxEO ¼ 0.073
nmol/min/mg protein (mean value, mice) and 0.055 nmol/min/
mg protein (mean value, rats). The curves shown in Figure 3
are ﬁtted to the data gained from mouse, rat, and human liver
microsomes considering saturation kinetics according to
Michaelis and Menten. The obtained VmaxEO and Km values
for mice and rats are given in Table 1. The VmaxEO values in
mice and rats are about double as high as in humans. The Km
value in humans is lower than that in rats and higher than that
in mice. When comparing the ratios VmaxEO/Km, human and rat
liver microsomes show almost the same values which are about
four times less than in mouse microsomes.
Table 2 shows the mean ± SE values of the rate constants of
the EO formation (k3), of the suicide inhibition (k4), and the
ratios k3/k4. The values of k3 were calculated by dividing
VmaxEO (Table 1) by the CYP2E1 content (Equation 23), the
values of k4 were obtained from the above-described six, eight,
and nine ET incubations of mouse, rat, and human liver
microsomes, respectively, and from incubations (two each) of
mouse and rat lung microsomes. The values of k4, reﬂecting
FIG. 2. Concentration-time courses of EO formed at various quasi-
constant atmospheric concentrations of ET in closed exposure vessels (38 ml)
containing hepatic or pulmonary microsomes. Produced EO is given as EO
concentration in the liquid phase of the incubation vessels. (A–C and H)
Incubations of pooled liver microsomes from (A) 50 B6C3F1 mice (2.5 mg
protein/ml, incubation volume 4 ml), (B) 10 rats (5 mg protein/ml, incubation
volume 4 ml), (C) 25 humans (10 mg protein/ml, incubation volume 2 ml), (H)
50 wild-type mice (2.5 mg protein/ml, incubation volume 4 ml), and 50
CYP2E1 knockout mice (10 mg protein/ml, incubation volume 2 ml). (D and
E) Incubations of liver microsomes of 10 mg protein/ml (incubation volumes 2
ml each), from (D) a 75-year-old female human subject and (E) a 22-year-old
male human subject. (F and G) Incubations (2 ml each) of pooled lung
microsomes from (F) 150 mice (5 mg protein/ml) and (G) 50 rats (10 mg
protein/ml). ET exposure concentrations and data symbols are given by (A) 200
ppm ( ), 720 ppm ( ), 2720 ppm ( ), 7040 ppm ( ), 36300 ppm ( ), 56700
ppm ( ); (B) 210 ppm ( ), 810 ppm ( ), 3010 ppm ( ), 7580 ppm ( ),
14200 ppm ( ), 37800 ppm ( ), 55700 ppm ( ), 76900 ppm ( ); (C)
260 ppm ( ), 1380 ppm ( ), 3300 ppm ( ), 10300 ppm ( ), 39700 ppm ( );
(D) 66300 ppm ( ); E) 270 ppm ( ), 3110 ppm ( ), 38600 ppm ( ); (F)
16500 ppm ( ), 75400 ppm ( ); (G) 18600 ppm ( ), 57800 ppm ( ); (H)
1200 ppm ( ), 3420 ppm ( ), 8910 ppm ( ), 39800 ppm ( ), 10600 ppm
( ), 20100 ppm ( ), 30800 ppm ( ), 38300 ppm ( ). Lines are ﬁts of
Equation 8 to the data. The experiments represented by colors (Figs. 2A–C) are
identical with those in Figures 1D–1F. The insert in Figure 2H enlarges the
concentration-time courses obtained in ET exposed CYP2E1 knockout mice.
TABLE 1
Maximum EO Formation Rates (VmaxEO) and Corresponding
Apparent Michaelis Constants (Km) in ET-Exposed Mouse, Rat,
and Human Hepatic Microsomes (Means ± SEs)
Species
VmaxEO
(nmol/min/mg
protein)
Km
(mmol/l
ET in suspension)
VmaxEO/Km
(ll/min/mg
protein)
Mouse
a 0.567 ± 0.038 0.0093 ± 0.003 60.9 ± 21.0
Rat
a 0.401 ± 0.013 0.031 ± 0.005 13.1 ± 2.0
Human
a 0.219 ± 0.005 0.013 ± 0.001 17.2 ± 1.5
Human
b 0.253 ± 0.0002 0.016 ± 0.000 15.6 ± 0.1
aPooled from the livers of 50 mice, 10 rats, or 25 humans.
bFrom one male individual.
390 LI ET AL.a reaction occurring within the porphyrin ring, are rather
similar between the species. Those of k3 are highest in rat and
lowest in human livers. These ﬁndings might be caused by
species differences in active site amino acid residues of
CYP2E1 (Lewis et al., 1997). As a result, the partition ratio k3/
k4 is several times smaller in liver microsomes of humans than
of rodents. This might be interpreted as a hint that humans
could be less sensitive to eventual toxic effects from ET via the
formation of EO. The values of the presently determined
partition ratios are in agreement with the common observed
values of less than 300 in unconjugated terminal oleﬁns
(Correia and Ortiz de Montellano, 2005).
The values of k4 in lung microsomes of mice and rats are ﬁve
and eight times larger than in liver microsomes of both species.
The high k4 values are unlikely to result from a bias in the
interpretation of the EO concentration-times curves in lung
microsomes because these microsomes were stable and metabol-
ically active during the exposure time as was tested using the
model substance styrene (data not shown). At present, we could
only speculate why k4 of the ET metabolism is organ-speciﬁc.
Gas Uptake Studies with EO in Microsomal Incubations
Figure 4 shows the results of EO uptake experiments in pooled
hepatic microsomes of mice (Fig. 4A), rats (Fig. 4B), or humans
(Fig. 4C), in hepatic microsomes of two adult human individuals
(Fig. 4D) and in pooled lung microsomes of mice (Fig. 4E)o rr a t s
(Fig. 4F). In order to assess the microsomal functionality, uptake
studies were carried out using the homologous PO and the same
native pooled microsomes of mouse and rat livers as were
prepared for the EO experiments. The slopes of the curves
depicting the hepatic microsomal elimination of PO were about
10 times steeper than those of the corresponding EO curves (Fig.
4A and 4B), thereby proving the microsomal EH activity. With
PO, about the same hepatic microsomal elimination clearances
(ll/min/mg protein) were obtained as had been found earlier
(mouse 4.4 and rat 9.9; Faller et al., 2001). In spite of this, the
slopes of the curves showing the EO elimination from the gas
phase of the vessels containing native hepatic or pulmonary
rodent microsomes were not distinguishable from those repre-
senting the spontaneous hydrolysis of EO, which was determined
in 15 experiments with heat-inactivated microsomes of the three
species (Figs. 4A–F). In other words, no EH-catalyzed EO
elimination was found. Also, no CYP-mediated EO elimination
was detected as was assayed for in a rat liver microsomal
incubation containing an NADPH-regenerating system. In pooled
native human liver microsomes, however, the EO elimination was
clearly faster than in the heat-inactivated ones. The concentration-
dependent ﬂattening of the slopes hints to saturation kinetics of
the EO elimination (Fig. 4C). From the best ﬁts to the data by
means of Berkeley Madonna, a Vmax value of 14.35 nmol/min/mg
protein was derived. The Km value in the microsomal
environment was 12.74 mmol/l, and the ratio of Vmax to Km
was 1.13 ll/min/mg protein. The maximum EO production rates
in microsomal incubations with ET (Table 1) were calculated
without considering the microsomal elimination of EO and the
loss of EO by spontaneous hydrolysis. The resulting error is
negligible for rodents. For humans, it does not exceed 10% of the
maximum production rate.
The slopes of the EO concentration-time curves of liver
microsomes prepared from the two adults (Fig. 4D) were
almost identical with the one obtained in pooled human
microsomes at 100 ppm (see Fig. 4C).
Gas Uptake Studies with EO in Cytosolic Incubations
Figure 5 depicts time courses of atmospheric EO concen-
trations in incubations of GSH- or DEM-containing native or
heat-inactivated pooled hepatic cytosol from mice, rats, and
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FIG. 3 Initial formation rates of EO versus atmospheric ET exposure
concentrations in liver microsomes of mice, rats, and humans, and in lung
microsomes of mice and rats. Symbols, initial EO formation rates: pooled liver
microsomes from ( ) 50 mice, ( ) 10 rats, ( ) 25 humans; liver microsomes
from ( ) a 75-year-old human female and ( ) a 22-year-old male human
subject; pooled lung microsomes from ( ) 150 mice and ( ) 50 rats. Lines
represent Michaelis-Menten kinetics ﬁtted to the data obtained in liver
microsomes or averages of the values obtained in lung microsomes.
TABLE 2
ET-Speciﬁc Catalytic Rate Constants k3 in Liver and Lung
Microsomes, and Suicide Inactivation Rate Constants k4 as well
as Partition Ratios k3/k4 in Liver Microsomes of Mice, Rats, or
Humans (Means ± SEs)
Species Organ k3 (min
 1)k 4 (min
 1)k 3/k4
Mouse Liver
a 5.9 ± 0.6 0.060 ± 0.005 100 ± 9
Lung
b n.a. 0.306; 0.326 n.a.
Rat Liver
a 11.2 ± 1.5 0.070 ± 0.006 169 ± 15
Lung
b n.a. 0.573; 0.392 n.a.
Human Liver
a 3.2 ± 0.2 0.098 ± 0.013 39 ± 6
Note. n.a., not available.
aPooled from livers of 50 mice, 10 rats, or 25 humans.
bPooled from lungs of 150 mice or 50 rats.
ETHYLENE AND ETHYLENE OXIDE KINETICS IN RODENT AND HUMAN TISSUES 391humans (Figs. 5A–C) or GSH- or DEM-containing native or
heat-inactivated pooled pulmonary cytosol from mice and rats
(Figs. 5D and 5E). The slopes of the EO-concentration-time
courses in the GSH-containing incubations with native cytosol
are clearly different from those with GSH-depleted heat-
inactivated cytosol. It is meaningful to compare the species-
speciﬁc EO elimination by GSH conjugation directly from the
ﬁgure because all incubations contained the same amount of
cytosolic protein. Obviously, the conjugation rates are highest in
mouse and lowest in human cytosol. In the semilogarithmic
plots, the elimination curves are parallel over the whole exposure
ranges up to about 3000 ppm and do not show any hint to
saturation kinetics. In spite of this, the conjugation reaction was
catalyzed by GST as has to be concluded from the evidently
ﬂatter slopes of the curves obtained in heat-inactivated GSH-
containing cytosolic EO incubations. They represent the sum of
both the spontaneous EO hydrolysis and the nonenzymatic
conjugation of EO with GSH. The elimination rate constant
resulting from the nonenzymatic conjugation reaction only was
calculated to be 3.12 3 10
 3 ± 3.0 3 10
 4 min
 1 (means ± SE,
n ¼ 8; three measurements in heat-inactivated liver cytosol of
human individuals included) corresponding to a mean half-life of
3.7 h. At the same GSH concentration of 15 mmol/l, Faller et al.
(2001) reported a half-life of 1.7 h for the nonenzymatic GSH
conjugation of the homologous PO.
The slopes of the curves obtained with heat-inactivated, DEM
containing or with native, DEM-containing liver or lung cytosol
did not differ signiﬁcantly within and between each species.
They were also not different from those obtained in Figure 4
with heat-inactivated microsomal EO incubations (p < 0.05; one-
way ANOVA) representing the spontaneous hydrolysis. When
calculating the parameters of enzyme-catalyzed reactions, non-
enzymatic GSH conjugation and spontaneous hydrolysis were
accounted for. The rate constant of the spontaneous EO
hydrolysis was 9.3 3 10
 4 ± 7 3 10
 5 min
 1 (mean ± SE,
n ¼ 36). The corresponding mean half-life was 12.4 h. Faller
et al. (2001) determined at pH 7.4 and 37 C a similar half-life of
the spontaneous hydrolysis of PO (16 h) using also a MgCl2
containing potassium phosphate buffer which has some catalytic
activity due to its nucleophilic nature (Bundgaard and Hansen,
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FIG. 4. Concentration-time courses of atmospheric EO or PO at various initial concentrations in closed exposure vessels containing microsomes (5 mg
protein/ml, incubation volume 1 ml, and vessel volume 38 ml) from pooled livers of (A) 50 mice, (B) 10 rats, or (C) 25 humans, from livers of (D) a 75-year-old
female or a 22-year-old male human subject, and from pooled lungs of (E) 150 mice and (F) 50 rats. Symbols, measured data, A–C, E, and F: ( ) EO exposures
using pooled heat-inactivated microsomes from livers or lungs, ( ) EO exposures using pooled native liver or lung microsomes, ( ) PO exposures using pooled
native liver microsomes; D: EO exposures using ( ) heat-inactivated liver microsomes from a 22-year-old human subject or native liver microsomes from ( )
a 75-year-old female or ( ) a 22-year-old male human subject. Lines, ﬁts of Equation 3 to the data.
392 LI ET AL.1981). Longer half-lives of between 77 and 99 h (EO) and of 88
h (PO) were estimated for the noncatalyzed aqueous hydrolysis
at 37 C, pH 7 (reported in Faller et al.,2 0 0 1 ).
The observed ﬁrst-order decays in the EO concentrations
signify that the rate of the GST-mediated EO elimination was
directly proportional to the EO exposure concentration, the
highest of which (3000 ppm) corresponds to an EO
concentration of 9 mmol/l in the cytosolic suspension.
The EO-eliminating human GSTT1 (GST-theta; Fo ¨st et al.,
1991, 1995) shows polymorphism, which may be genotoxically
relevant (Hallier et al.,1 9 9 3 ). Therefore, the GST-mediated
conjugation of EO with GSH was additionally investigated in
liver cytosol of six male and seven female individuals of between
16 and 78 years of age. The results are summarized in Table 3
together with those obtained in cytosol pooled from livers of 50
mice, 10 rats, or 11 humans or pooled from lungs of 150 mice or
50 rats. Only the ratio Vmax/Km is given because of the ﬁrst-order
kinetics observed for the GST-catalyzed EO elimination. The
ratio was obtained by dividing the product of the rate constant of
the GST-dependent EO elimination with Vd by the product of
KeqEO with the actual amount of protein. The GST activity in
pooled human liver cytosol is reasonably in the middle between
the lowest individual GST activity (zero) and the highest one
(2.87 ll/min/mg protein). The time span between death and
autopsy did presumably not inﬂuence the GST activity because
of the 13 hepatic cytosol samples obtained from non-Asian
individuals, highest GST activities were found in the samples of
a 22- and 42-year-old man, who died 6.5 and 29 h, respectively,
prior to autopsy. Two samples (15%) did not show any GST
activity to EO. The percentage agrees with that of the GSTT1*0
carriers reported for non-Asians (between 10 and 25%; Bolt and
Thier, 2006).
In Johanson and Filser (1993), it was discussed that the
GST-catalyzed conjugation of GSH with an epoxide can be
described by saturation kinetics according to a sequentially
ordered ping-pong mechanism. For EO, the Km concentration
in livers or lungs of mice and rats and in livers of humans can
be concluded to be at least 9 mmol/l (equivalent to the highest
EO exposure concentration of 3000 ppm in cytosolic
incubations). The GST-catalyzed EO elimination rate is almost
independent of the GSH concentration at > 1 mmol/l because
the Km of GSH is only about 0.1 mmol/l (Csana ´dy and Filser,
2007; Johanson and Filser, 1993). Taking into account a Km
value of 9 mmol/l tissue for the GST substrate EO, Vmax values
(nmol/min/mg protein) of 251, 47.7, and 10.3 are obtained for
the GST-mediated GSH conjugation with EO in mouse, rat,
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FIG. 5 Concentration-time courses of atmospheric EO at various initial concentrations of EO in the atmosphere of closed exposure vessels (38 ml) with
incubations (1 ml) of GSH- or DEM-containing native or heat-inactivated pooled hepatic cytosol (3 mg protein/ml) from (A) 50 mice, (B) 10 rats, and (C) 11 humans
or GSH- or DEM-containing native or heat-inactivated pooled pulmonary cytosol (3 mg protein/ml) from (D) 150 mice and (E) 50 rats. Symbols, measured data, ( )
pooled heat-inactivated cytosol with DEM (3 mmol/l), ( ) pooled native cytosol with GSH (15 mmol/l), ( ) pooled native cytosol with DEM (3 mmol/l), ( ) pooled
heat-inactivated cytosol with GSH (15 mmol/l). Lines, ﬁts of Equation 3 to the data.
ETHYLENE AND ETHYLENE OXIDE KINETICS IN RODENT AND HUMAN TISSUES 393and human pooled liver cytosol, respectively. Corresponding
values for mouse and rat lung cytosol are 56.9 and 16.0.
DISCUSSION
Toxicokinetics of ET
If one assumes ET to be completely biotransformed to EO in
the ﬁrst metabolic step, EO formation rates should equal ET
elimination rates (i.e., jVmaxEOj ¼ jVmaxETj and Km for EO
formation ¼ Km of ET elimination). In Table 4, maximum rates
of ET elimination and atmospheric Km concentrations,
calculated for in vivo conditions from the in vitro results given
in Table 1, are compared with corresponding parameters
obtained in vivo from gas uptake studies. On average, the
predicted maximum ET elimination rates are around three
times higher than those observed in vivo. At a ﬁrst glance, these
results seem to be inconsistent. If, however, one bears in mind
the values of the suicide inactivation constant k4 of the ET-
metabolizing CYP2E1 (Table 2), one has to expect that the
amount of hepatic CYP2E1, which is available for the ET
oxidation, decreases in between 11 min (humans) and 18 min
(mice) to about one third of the initial status at very high ET
concentrations. In gas uptake studies with ET in rats (Bolt
et al., 1984)o rm i c e( Artati et al., 2009), this effect could not
be recognized from the concentration-time courses of ET in the
atmosphere because it occurs within the initial phase during
which the gas enriches in the organism. Predicted Km
concentrations in the atmosphere are 3.8- to 7.4-fold higher
than actually determined in vivo. However, the predicted
species-speciﬁc ratio VmaxET/Km does not differ by more than
a factor of two from the corresponding ratio obtained in vivo
(Table 4). This ratio, which reﬂects the clearance of
metabolism, is a direct measure of the metabolic elimination
of ET at low atmospheric ET concentrations at which the ET
elimination rate is proportional to the exposure concentration.
The agreement between the predicted and the in vivo obtained
VmaxET/Km values is striking. Because the in vivo-derived
values of VmaxET were obviously too low—not reﬂecting the
suicide inhibition—the corresponding in vivo Km values had
also to be too low in order to describe correctly the metabolic
elimination at low ET concentrations. For the same reason, an
extremely small value of 0.0005 mmol/l was used for the
apparent Michaelis constant of the ET oxidation in the liver
compartment of the physiological toxicokinetic ET model of
Csana ´dy et al. (2000).
Toxicokinetics of EO
The present results obtained in subcellular fractions of mouse
and rat livers can be compared with those of Brown et al. (1996)
who investigated the ethylene glycol formation in liver micro-
somes and cytosol of both species. In microsomal incubations,
the authors detected a maximum rate of hydrolysis of only 1.5–2
nmol/min/mg protein at an EO concentration of 15 mmol/l. The
rate was at best (assuming a protein concentration of 2 mg/ml
incubate) two times faster than the nonenzymatic hydrolysis. The
Km value for this reaction could only be estimated ‘‘due to the
high rate of nonenzymatic hydrolysis relative (to) the enzymatic
rate’’. One could argue, that the analytical method of Brown
et al. (1996) was more sensitive than the present one, where only
EO was quantiﬁed. However, the rate constant of the non-
enzymatic elimination could well be determined in this work. It
is almost identical with the value of 0.001 min
 1 that can be
calculated from the data given by Brown et al. (1996).I n
agreement with these authors, EO elimination takes place
predominantly in the cytosol and is catalyzed by GST. The
reported Vmax and Km values for GSH conjugation with EO in
liver cytosol of mice and rats are almost identical with those
obtained in the present work. From the high Km concentration of
9 mmol/l (mice, rats, and humans; this work) or 10 mmol/l (mice
and rats; Brown et al.,1 9 9 6 ), the EO metabolism in vivo can be
expected to be proportional to the EO exposure concentration
until the consumption of GSH that is required for the elimination
of EO will be too high to be counterbalanced by the GSH
turnover rate. Indeed, in single EO gas uptake studies with
Sprague-Dawley or Fischer rats, EO elimination from the
chamber atmosphere followed ﬁrst-order kinetics up to EO
TABLE 3
Activity of GST (Vmax/Km) in Mouse and Rat Hepatic and
Pulmonary Cytosol and in Human Hepatic Cytosol with
EO as Substrate (Mean ± SE, n 5 4)
Tissue Species Gender
Age
(years)
Vmax/Km
(ll/min/mg
protein)
Time
prior
to autopsy (h)
Liver Mouse
a Male 0.25 27.90 ± 2.87 0
Liver Rat
a Male 0.25 5.30 ± 0.10 0
Liver Human
b Both 1.9–70 1.14 ± 0.32 n.a.
Liver Human Female 51 0.00 ± 0.00 n.a.
Liver Human Female 54 0.00 ± 0.00 25
Liver Human Male 36 0.50 ± 0.25 23
Liver Human Male 63 0.54 ± 0.29 n.a.
Liver Human Male 16 0.75 ± 0.26 24
Liver Human Female 75 0.81 ± 0.34 0
d
Liver Human Female 78 1.21 ± 0.16 n.a.
Liver Human Female 42 1.36 ± 0.18 n.a.
Liver Human Male 58 1.49 ± 0.32 17
Liver Human Female 53 1.62 ± 0.32 n.a.
Liver Human Female 48 1.76 ± 0.46 n.a.
Liver Human Male 42 1.82 ± 0.51 29
Liver Human Male 22 2.87 ± 0.57 6.5
Lung Mouse
c Male 0.25 6.32 ± 0.52 0
Lung Rat
c Male 0.25 1.78 ± 0.33 0
Note. n.a., not available.
aPooled from livers of 50 mice or 10 rats.
bPooled from livers of ﬁve male and six female humans.
cPooled from lungs of 150 mice or 50 rats.
dLiver sample collected during transplantation.
394 LI ET AL.concentrations of about 600 ppm. At exposure concentrations of
about 1000 ppm, the concentration–time courses ﬂattened with
increasing exposure time (Csana ´dy et al.,2 0 0 0 ). Depletion of
GSH was most probably the cause for this effect considering that
McKelvey and Zemaitis (1986) observed a concentration-
dependent decrease of GSH in Fischer rats exposed for 4 h to
constant EO concentrations of 100, 600, or 1200 ppm. At the
highest EO concentration, GSH levels in the livers decreased to
less than 20% of the control value. In B6C3F1 mice exposed for
4 h to constant EO concentrations of up to 200 ppm, EO blood
levels were linearly related to the exposure concentration (Brown
et al.,1 9 9 8 ). At exposure concentrations of 300 and 400 ppm,
however, the EO blood levels increased overproportional when
related to the exposure concentration. The authors linked these
ﬁndings to a depletion of GSH. At EO concentrations of 300 and
400 ppm, GSH levels in the livers declined to less than 22% of
the control value (Brown et al.,1 9 9 8 ).
In contrast to mice and rats, EH-catalyzed hydrolysis of
EO is expected to represent at least one fourth of the overall
EO metabolism in humans. This ratio is obtained taking
into account a protein content of 30 mg/g liver in microsomes
and of 95 mg/g liver in cytosol (Kreuzer et al., 1991) as well
as a Vmax to Km ratio of the EH-catalyzed elimination
in microsomes of 1.13 ll/min/mg protein and of the
GST-catalyzed conjugation reaction in pooled cytosol of
1.14 ll/min/mg protein. Neglecting extrahepatic metabolism,
one can therefore expect for EO-exposed humans of the
GSTT1*0/0 genotype the EO tissue burden to be at most four
times higher than in equally exposed humans carrying the
active GSTT1 form. This conclusion of a quantitatively
relevant role of EH on the elimination of EO in humans is
supported by the results of a thoroughly conducted study on
smokers. Hydroxyethyl adduct levels to the N-terminal valine
of hemoglobin were on average 1.61 times higher in GSTT1-
null individuals than in GSTT1 carriers (Fennell et al., 2000).
EO Burden during ET Exposure
From the present parameters of EO production, CYP2E1
inhibition, and EO metabolism, one has to expect to ﬁnd in all
the three species, when exposed to high ET concentrations, an
early EO peak in blood followed by a rather rapid decline to
a plateau characterized by a distinctly lower equilibrium
between CYP2E1 neosynthesis and elimination as compared
with the initial CYP2E1 status. In the atmosphere of a closed
exposure chamber, the changes of the concentrations of
exhaled EO have to be slower and less drastic than the rapid
ones of EO in blood because the chamber behaves like a deep
compartment. The reported pictures of initial EO peaks in
blood and EO maxima in exhaled air of rats exposed to ET
concentrations > 300 ppm (Filser and Bolt, 1984; Maples and
Dahl, 1993) are in support of this expectation. At low ET
concentrations, the permanent resynthesis of CYP2E1 will be
large as compared with the rate of suicide inhibition and the
CYP2E1 turnover rate will not much change during exposure.
In agreement with the observation by Maples and Dahl (1993)
in rats, EO in blood and in chamber atmosphere is expected to
TABLE 4
Kinetic Parameters of Metabolic ET Elimination Predicted from In Vitro Data on Metabolically Produced EO and Determined In Vivo
in ET-Exposed Mice, Rats, and Humans
Species
Predicted from in vitro
a Determined in vivo
VmaxET
b (lmol/h/kg) Km
c (ppm in air) VmaxET/Km (lmol/h/kg/ppm) VmaxET (lmol/h/kg) Km (ppm in air) VmaxET/Km (lmol/h/kg/ppm)
Mouse 42.9 400 0.11 15
d 105
d 0.14
Rat 28.9 1516 0.02 8.5
e 204
e 0.04
8.6
f 218
f 0.04
Human 9.8 963 0.01 n.d. n.d. 0.005
g
Notes. VmaxET, maximum metabolic elimination rate of ET; Km, apparent Michaelis constant of the metabolic ET elimination, given as ET exposure
concentration in air; n.d., not determined.
aIt is assumed that the maximum rate of EO formation ðjVmaxEOjÞequalsjVmaxETj and that the Km concentrations of EO production and ET elimination are
identical. The parameters were predicted using the VmaxEO and Km values obtained in pooled liver microsomes.
bPredicted in vivo VmaxET was derived from VmaxEO (Table 1) as described in Kreuzer et al. (1991) taking into account a microsomal protein content of 30 mg/g
liver, liver weights of 1 g (mouse), 10 g (rat), and 1.5 kg (human), and body weights of 25 g (mouse), 250 g (rat), and 70 kg (human).
cKm (ppm) was calculated by dividing the in Table 1 given Km (mmol/l suspension) by the in vivo obtained steady-state bioaccumulation factor Kst, which gives
the ratio of the average ET concentration in the body at low ET exposure concentrations to the ET exposure concentration in the atmosphere—Kst ¼ 0.55 (mouse,
to be published), Kst ¼ 0.50 (rat, Bolt et al., 1984), and Kst ¼ 0.33 (human, Filser et al., 1992)—and by multiplication with 24,450 ml, the molar volume of an ideal
gas at 25 C.
dFrom Artati et al. (2009).
eFrom Bolt et al. (1984).
fFrom Andersen et al. (1980).
gValue was calculated by dividing the ‘‘clearance of metabolism (related to the atmosph. concn.)’’ of 9.3 l/h (Table 2 in Filser et al., 1992) by 24.45 l, the molar
volume of an ideal gas at 25 C, and by a body weight of 70 kg.
ETHYLENE AND ETHYLENE OXIDE KINETICS IN RODENT AND HUMAN TISSUES 395increase continuously until reaching a plateau that is simply
characterized by the equilibrium between EO formation (from
ET) and EO elimination.
Outlook
A presently favored procedure to evaluate human health risks
from chemicals uses toxicokinetic and toxicodynamic chemical-
speciﬁc adjustment factors (CSAFs) in dose-response assessment
(see, for example, Meek et al.,2 0 0 2 ). Usually, the CSAF for the
toxicokinetic uncertainty between species and that for the
toxicokinetic uncertainty between human individuals is given
a maximum number of 10
0.6 and of 10
0.5, respectively. In our
laboratory, we are just ﬁnishing studies on the EO burden in ET-
exposed mice, rats, and human individuals. The results together
with the robust toxicokinetic parameters obtained in the present
work will be used to improve a physiological toxicokinetic
model (Csana ´dy et al.,2 0 0 0 ) for ET and EO in these three
species. Because of its strong interspecies and interindividual
data basis, we expect model predictions to be reliable enough for
reducing the toxicokinetic CSAFs to the minimum.
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